Homocysteine, folate deprivation and Alzheimer neuropathology
- 25 September 2002
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer's Disease
- Vol. 4 (4) , 261-267
- https://doi.org/10.3233/jad-2002-4401
Abstract
Increased levels of homocysteine (HC), arising in some situations via deficiencies in folate – an essential cofactor in metabolic regulation of HC – have long been known to contribute to cardiovascular disorders and stroke. More recently, clinical stThis publication has 12 references indexed in Scilit:
- Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's DiseaseJournal of Neuroscience, 2002
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's diseaseJournal of Neurochemistry, 2001
- Differential efficacy of lipophilic and cytosolic antioxidants on generation of reactive oxygen species by amyloid-βJournal of Alzheimer's Disease, 2001
- Homocysteine potentiates β‐amyloid neurotoxicity: role of oxidative stressJournal of Neurochemistry, 2001
- Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to ExcitotoxicityJournal of Neuroscience, 2000
- Functional methionine synthase deficiency (cblE and cblG): Clinical and biochemical heterogeneityAmerican Journal of Medical Genetics, 1989
- Demyelination and decreased S ‐adenosylmethionine in 5.10‐methylenetetrahydrofolate reductase deficiencyNeurology, 1988
- THE NATURAL-HISTORY OF HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY1985
- BIOCHEMICAL INVESTIGATIONS AND TRISOMY-211979